Spots Global Cancer Trial Database for Induction Chemotherapy for Locally Recurrent Rectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Induction Chemotherapy for Locally Recurrent Rectal Cancer
Official Title: Multicentre, Open-label, Randomised, Controlled, Parallel Arms Clinical Trial of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone as Neoadjuvant Treatment for Locally Recurrent Rectal Cancer - PelvEx II
Study ID: NCT04389086
Conditions
Study Description
Brief Summary: This is a multicentre, open-label, parallel arms, phase IIII study that randomises patients with locally recurrent rectal cancer in a 1:1 ratio to receive either induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery (experimental arm) or neoadjuvant chemoradiotherapy and surgery alone (control arm)
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
UZ Gent, Gent, , Belgium
Amsterdam UMC, Amsterdam, , Netherlands
Antoni van Leeuwenhoek, Amsterdam, , Netherlands
Catharina Hospital, Eindhoven, , Netherlands
University Medical Centre Groningen, Groningen, , Netherlands
Leids University Medical Centre, Leiden, , Netherlands
Haaglanden Medical Centre, Leidschendam, , Netherlands
Maastricht University Medical Centre, Maastricht, , Netherlands
Erasmus Medical Centre, Rotterdam, , Netherlands
Oslo Universitetssykehus, Oslo, , Norway
Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon, , Portugal
Sahlgrenska Universitetssjukhuset, Göteborg, , Sweden
Skåne Universitetssjukhuset, Malmö, , Sweden
Karolinska Universitetssjukhuset, Stockholm, , Sweden
Contact Details
Name: Pim Burger, MD
Affiliation: Catharina Ziekenhuis Eindhoven
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
